Physician

Mary Patricia Lange, M.D.

According to 2025 Medicare claims, Mary Lange, M.D. (NPI: 1578502019) practices ophthalmology in the Lawrence, KS market, with the plurality of this provider's patient population coming from Douglas, KS. This provider's primary affiliated billing organization is LAWRENCE EYE CARE ASSOCIATES, P.A. (NPI: 1588619779; TIN: 480842315) and primary practice location at 66044-1838.

Lange's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,077 traditional Medicare patients, billed 2,844 HCPCS/CPT codes, and received $185,795 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,241 prescription claims across 240 beneficiaries totaling $163,861 in drug costs, led by Restasis (Cyclosporine). DME data shows 29 claims. Open Payments data shows 13 records totaling $230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $122,151 to $163,861. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,217	2,671	$236,144
2016	1,329	3,274	$258,511
2017	1,433	3,705	$275,941
2018	1,281	3,417	$265,739
2019	1,292	3,500	$280,785
2020	1,142	2,962	$210,927
2021	1,277	3,362	$253,237
2022	1,238	3,341	$221,373
2023	1,151	3,409	$242,221
2024	1,077	2,844	$185,795

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	292	1,181	$122,151
2016	311	1,332	$160,712
2017	312	1,269	$158,178
2018	330	1,513	$197,908
2019	294	1,371	$192,460
2020	254	1,223	$194,440
2021	268	1,362	$205,769
2022	264	1,421	$230,167
2023	253	1,395	$237,648
2024	240	1,241	$163,861

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	75	75	$5,058
2016	74	74	$4,571
2017	87	89	$6,084
2018	46	46	$2,744
2019	59	59	$3,820
2020	43	45	$2,552
2021	58	59	$3,981
2022	44	44	$3,170
2023	29	29	$1,884
2024	29	29	$2,609

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	794	830	$78
92014	Established patient complete exam of visual system	129	129	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	400	621	$58
92134	Imaging of retina	300	370	$23
92133	Imaging of optic nerve	239	246	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	76	2,670	$55,798
Lumigan	Bimatoprost	105	3,517	$31,113
Vyzulta	Latanoprostene Bunod	35	917	$10,152
Combigan	Brimonidine Tartrate/Timolol	31	1,148	$9,740
Rocklatan	Netarsudil Mesylat/Latanoprost	14	400	$4,642

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	16	16	$1,830
V2020	Frames, purchases	N	13	13	$780

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$230	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mary Patricia Lange, M.D.?

Tedicare shows public-source Medicare data for Mary Patricia Lange, M.D. (NPI 1578502019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary Patricia Lange, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mary Patricia Lange, M.D.?

Mary Patricia Lange, M.D. is linked to LAWRENCE EYE CARE ASSOCIATES, P.A. (billing NPI 1588619779) in the available physician profile data.

Does Mary Patricia Lange, M.D. have Open Payments data?

Mary Patricia Lange, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.